Clinical Trials
22 trialsNCT06747169 2024-12-27
Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Second Affiliated Hospital of Zunyi Medical University
Phase 2 Not yet recruiting
NCT06279754 2024-02-28
Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy
The First Affiliated Hospital of Xinxiang Medical College
Phase 2 Unknown
NCT05574998 2022-10-12
FTANLCNDG
Qianfoshan Hospital
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT05448781 2022-07-07
Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Unknown
NCT05360979 2022-05-04
A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC
Second Xiangya Hospital of Central South University
Phase 2 Unknown
NCT05243355 2022-02-17
Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Qilu Hospital of Shandong University
Phase 2 Unknown
NCT04613284 2020-11-03
RELIEF
Shanghai Chest Hospital
Phase 4 Unknown
NCT01733589 2017-07-14
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
Zhejiang Cancer Hospital
Phase 1/2 Completed
NCT03123445 2017-04-21
Endostar First-line Treatment of Advanced NSCLC
China Medical University, China
Phase 2 Unknown
NCT02579564 2016-10-21
Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Xinqiao Hospital of Chongqing
Phase 3 Unknown
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed
NCT02375022 2015-03-24
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Zhejiang University
Phase 2 Unknown
NCT02350361 2015-01-29
Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.
Peking University Third Hospital
Phase 2/3 Unknown
NCT02005120 2013-12-20
Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC
Zhejiang University
Phase 2 Unknown
NCT01347424 2013-12-09
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
Sun Yat-sen University
Phase 2 Unknown
NCT01218594 2012-10-17
DP-EN-RT
Sun Yat-sen University
Phase 2 Unknown
NCT01211002 2010-09-29
Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)
Simcere Pharmaceutical Co., Ltd
Phase 4 Unknown
NCT01192230 2010-09-16
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
Fudan University
Phase 2 Unknown
NCT01158144 2010-07-08
Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT01124253 2010-05-17
Dengshan
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT01028729 2009-12-09
NSCLC
Simcere Pharmaceutical Co., Ltd
Phase 4 Unknown